JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB54797

Anti-DPD antibody [7D4]

Be the first to review this product! Submit a review

|

(10 Publications)

Mouse Monoclonal DPD antibody. Suitable for Flow Cyt, WB, ICC/IF and reacts with Human samples. Cited in 10 publications. Immunogen corresponding to Recombinant Fragment Protein within Human Dihydropyrimidine dehydrogenase [NADP(+)] aa 1-150.

View Alternative Names

Dihydropyrimidine dehydrogenase [NADP(+)], DHPDHase, DPD, Dihydrothymine dehydrogenase, Dihydrouracil dehydrogenase, DPYD

3 Images
Immunocytochemistry/ Immunofluorescence - Anti-DPD antibody [7D4] (AB54797)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-DPD antibody [7D4] (AB54797)

ab54797 at 10 ug/ml staining DPD in human Hela cells by Immunocytochemistry / Immunofluorescence.

This image was generated using the ascites version of the product.

Flow Cytometry - Anti-DPD antibody [7D4] (AB54797)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-DPD antibody [7D4] (AB54797)

Overlay histogram showing HepG2 cells stained with ab54797 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab54797, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HepG2 cells fixed with 100% methanol (5 min)/permeabilized in 0.1% PBS-Tween used under the same conditions.

This image was generated using the ascites version of the product.

Western blot - Anti-DPD antibody [7D4] (AB54797)
  • WB

Unknown

Western blot - Anti-DPD antibody [7D4] (AB54797)

DPD antibody (ab54797) at 1ug/lane + HeLa cell lysate at 25ug/lane.

This image was generated using the ascites version of the product.

All lanes:

Western blot - Anti-DPD antibody [7D4] (ab54797)

Predicted band size: 111 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

7D4

Isotype

IgG1

Light chain type

kappa

Carrier free

No

Reacts with

Human

Applications

ICC/IF, WB, Flow Cyt

applications

Immunogen

Recombinant Fragment Protein within Human Dihydropyrimidine dehydrogenase [NADP(+)] aa 1-150. The exact immunogen used to generate this antibody is proprietary information.

Q12882

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" } } }

Product details

This product was changed from ascites to tissue culture supernatant on 12/3/19. Please note that the dilutions may need to be adjusted accordingly. If you have any questions, please do not hesitate to contact our scientific support team.

Properties and storage information

Form
Liquid
Purity
Tissue culture supernatant
Storage buffer
pH: 7.4
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

DPD also known as dihydropyrimidine dehydrogenase is an enzyme important for the breakdown of pyrimidines particularly uracil and thymine. The DPD protein has an important role in the initial step of pyrimidine catabolism. It catalyzes the NADPH-dependent reduction of these pyrimidines to dihydrouracil and dihydrothymine. It consists of 1025 amino acids giving it a mass of approximately 111 kDa. DPD is expressed in various tissues with significant expression in the liver and to a lesser extent in peripheral blood lymphocytes.
Biological function summary

Dihydropyrimidine dehydrogenase impacts nucleotide metabolism which is significant for cellular replication and repair processes. DPD exists as part of a multi-enzyme complex that handles pyrimidine metabolism. It serves an important regulatory function by controlling the level of pyrimidines within cells. This regulation keeps the balance of free nucleotides which is critical for DNA synthesis and overall cellular homeostasis.

Pathways

DPD holds an important position in pyrimidine metabolism pathways and the drug metabolism pathway specifically influencing fluoropyrimidine-based chemotherapeutic agents. Within the pyrimidine metabolic pathway DPD links to other enzymes that further breakdown pyrimidines into more basic compounds. In drug metabolism DPD plays a vital role by metabolizing drugs like 5-fluorouracil. Its activity affects how individuals process these medications linking it to enzymes like thymidylate synthase that share pathways in cancer treatment drug action.

DPD deficiency relates to a genetic disorder that causes an excessive build-up of uracil and thymine leading to developmental disorders and neurological problems. Additionally abnormalities in DPD activity influence the efficacy and toxicity of fluorouracil chemotherapy in cancer treatments. DPD enzymatic activity when not properly regulated can lead to severe toxic reactions especially in relation to therapies reliant on enzymes such as thymidylate synthase emphasizing the critical interplay between these proteins in the management of fluoropyrimidine drug treatments.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Involved in pyrimidine base degradation (PubMed : 1512248). Catalyzes the reduction of uracil and thymine (PubMed : 1512248). Also involved the degradation of the chemotherapeutic drug 5-fluorouracil (PubMed : 1512248).
See full target information Dihydropyrimidine dehydrogenase [NADP(+)]

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Scientific reports 12:8535 PubMed35595780

2022

Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine.

Applications

Unspecified application

Species

Unspecified reactive species

Shigehiro Tsukahara,Masaki Shiota,Dai Takamatsu,Shohei Nagakawa,Takashi Matsumoto,Ryo Kiyokoba,Mikako Yagi,Daiki Setoyama,Nozomi Noda,Shinya Matsumoto,Tetsutaro Hayashi,Alberto Contreras-Sanz,Peter C Black,Junichi Inokuchi,Kenichi Kohashi,Yoshinao Oda,Takeshi Uchiumi,Masatoshi Eto,Dongchon Kang

Antioxidants & redox signaling 30:542-559 PubMed29486586

2018

Single-Cell Transcriptomics of Human Oocytes: Environment-Driven Metabolic Competition and Compensatory Mechanisms During Oocyte Maturation.

Applications

Unspecified application

Species

Unspecified reactive species

Hongcui Zhao,Tianjie Li,Yue Zhao,Tao Tan,Changyu Liu,Yali Liu,Liang Chang,Ning Huang,Chang Li,Yong Fan,Yang Yu,Rong Li,Jie Qiao

Oncotarget 8:112060-112075 PubMed29340111

2017

Effect of dihydropyrimidine dehydrogenase single nucleotide polymorphisms on prognosis of breast cancer patients with chemotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Fengxia Qin,Huikun Zhang,Yong Huang,Limin Yang,Feng Yu,Xiaoli Liu,Li Fu,Feng Gu,Yongjie Ma

Cancer research 76:6362-6373 PubMed27578004

2016

Histone H3K27 Trimethylation Modulates 5-Fluorouracil Resistance by Inhibiting PU.1 Binding to the DPYD Promoter.

Applications

WB

Species

Unspecified reactive species

Rentian Wu,Qian Nie,Erin E Tapper,Calvin R Jerde,Garrett S Dunlap,Shikshya Shrestha,Tarig A Elraiyah,Steven M Offer,Robert B Diasio

Journal of hepato-biliary-pancreatic sciences 23:480-8 PubMed27247050

2016

Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Atsushi Oba,Daisuke Ban,Susumu Kirimura,Keiichi Akahoshi,Yusuke Mitsunori,Satoshi Matsumura,Takanori Ochiai,Atsushi Kudo,Shinji Tanaka,Tanabe Minoru

Cancer research 74:2545-54 PubMed24648345

2014

Comparative functional analysis of DPYD variants of potential clinical relevance to dihydropyrimidine dehydrogenase activity.

Applications

WB

Species

Unspecified reactive species

Steven M Offer,Croix C Fossum,Natalie J Wegner,Alexander J Stuflesser,Gabriel L Butterfield,Robert B Diasio

Molecular cancer therapeutics 13:742-51 PubMed24401318

2014

microRNAs miR-27a and miR-27b directly regulate liver dihydropyrimidine dehydrogenase expression through two conserved binding sites.

Applications

WB

Species

Unspecified reactive species

Steven M Offer,Gabriel L Butterfield,Calvin R Jerde,Croix C Fossum,Natalie J Wegner,Robert B Diasio

Cancer research 73:1958-68 PubMed23328581

2013

Phenotypic profiling of DPYD variations relevant to 5-fluorouracil sensitivity using real-time cellular analysis and in vitro measurement of enzyme activity.

Applications

WB

Species

Human

Steven M Offer,Natalie J Wegner,Croix Fossum,Kangsheng Wang,Robert B Diasio

Proceedings of the National Academy of Sciences of 106:12938-43 PubMed19622726

2009

Identification of genes conferring resistance to 5-fluorouracil.

Applications

WB

Species

Human

Byoung Kwon Yoo,Rachel Gredler,Nicollaq Vozhilla,Zao-zhong Su,Dong Chen,Talitha Forcier,Khalid Shah,Utsav Saxena,Ulla Hansen,Paul B Fisher,Devanand Sarkar

The Journal of clinical investigation 119:465-77 PubMed19221438

2009

Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression.

Applications

IHC-P

Species

Human

Byoung Kwon Yoo,Luni Emdad,Zao-zhong Su,Augusto Villanueva,Derek Y Chiang,Nitai D Mukhopadhyay,Alan Scott Mills,Samuel Waxman,Robert A Fisher,Josep M Llovet,Paul B Fisher,Devanand Sarkar
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com